meta-analysis | Q815382 |
scholarly article | Q13442814 |
P50 | author | Florian Holsboer | Q1429723 |
Marcella Rietschel | Q20742720 | ||
Sven Cichon | Q28050103 | ||
Jana Strohmaier | Q34568406 | ||
Manuel Mattheisen | Q37357032 | ||
Francis J. McMahon | Q37369592 | ||
Markus M Nöthen | Q37634364 | ||
Federica Tozzi | Q47502259 | ||
Thomas G. Schulze | Q61995101 | ||
Thomas W Mühleisen | Q87871468 | ||
Jens R Wendland | Q88037498 | ||
Pierandrea Muglia | Q89919709 | ||
Martin Preisig | Q90376398 | ||
René Breuer | Q114270577 | ||
Nirmala Akula | Q114370003 | ||
John B Vincent | Q115588965 | ||
P2093 | author name string | Anne Farmer | |
Wolfgang Maier | |||
Sevilla D Detera-Wadleigh | |||
C J M Steele | |||
Bipolar Disorder Genome Study (BiGS) Consortium | |||
P2860 | cites work | Estimation of significance thresholds for genomewide association scans | Q24289532 |
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
Genome-wide association study of bipolar disorder in European American and African American individuals | Q24628870 | ||
A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder | Q24655759 | ||
PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells | Q24682602 | ||
A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder | Q28250609 | ||
Whole-genome association study of bipolar disorder | Q28271419 | ||
A framework for interpreting genome-wide association studies of psychiatric disorders | Q28300576 | ||
Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk | Q28303293 | ||
Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry | Q28943449 | ||
Genomic control for association studies | Q29547213 | ||
A HapMap harvest of insights into the genetics of common disease | Q29614875 | ||
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits | Q29614876 | ||
Genome-wide association of major depression: description of samples for the GAIN Major Depressive Disorder Study: NTR and NESDA biobank projects | Q30483668 | ||
Tissue-specific genetic control of splicing: implications for the study of complex traits | Q33409947 | ||
Cis-acting expression quantitative trait loci in mice | Q33771852 | ||
Polybromo-1: the chromatin targeting subunit of the PBAF complex | Q37107294 | ||
Genotype-imputation accuracy across worldwide human populations | Q37156125 | ||
Impairment in role functioning in mental and chronic medical disorders in the United States: results from the National Comorbidity Survey Replication | Q37238643 | ||
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis | Q37299016 | ||
Interpretation of tests of heterogeneity and bias in meta-analysis | Q37329334 | ||
Global burden of depressive disorders in the year 2000 | Q56814477 | ||
A survey of genetic human cortical gene expression | Q57272923 | ||
Genome-wide association study of recurrent major depressive disorder in two European case–control cohorts | Q57323019 | ||
Systematic Reviews and Meta-Analysis | Q57970162 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mood disorder | Q188638 |
meta-analysis | Q815382 | ||
genome-wide association study | Q1098876 | ||
P304 | page(s) | 128-131 | |
P577 | publication date | 2010-01-17 | |
P1433 | published in | Nature Genetics | Q976454 |
P1476 | title | Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. | |
P478 | volume | 42 |
Q36206875 | A 3p26-3p25 genetic linkage finding for DSM-IV major depression in heavy smoking families |
Q37582988 | A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation |
Q29417101 | A genome-wide association study of attempted suicide. |
Q37407150 | A large-scale candidate gene analysis of mood disorders: evidence of neurotrophic tyrosine kinase receptor and opioid receptor signaling dysfunction |
Q29417093 | A mega-analysis of genome-wide association studies for major depressive disorder |
Q33543143 | A new statistic to evaluate imputation reliability |
Q36478862 | Aberrant executive attention in unaffected youth at familial risk for mood disorders |
Q89863903 | An atlas of genetic correlations between psychiatric disorders and human blood plasma proteome |
Q37978823 | Animal models of stress vulnerability and resilience in translational research. |
Q39231042 | Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia |
Q47796306 | Association at SYNE1 in both bipolar disorder and recurrent major depression |
Q93002221 | Association of SYNE1 locus with bipolar disorder in Chinese population |
Q37981617 | Behavioral Genetics of Affective and Anxiety Disorders |
Q37412479 | Common variant at 16p11.2 conferring risk of psychosis. |
Q47334914 | Common variants at 2q11.2, 8q21.3, and 11q13.2 are associated with major mood disorders. |
Q35804142 | Comparative genome-wide association studies of a depressive symptom phenotype in a repeated measures setting by race/ethnicity in the Multi-Ethnic Study of Atherosclerosis |
Q39495606 | Comparison of gene expression profiles in the blood, hippocampus and prefrontal cortex of rats |
Q36850500 | Converging Evidence for Epistasis between ANK3 and Potassium Channel Gene KCNQ2 in Bipolar Disorder |
Q33361975 | Copy number variations play important roles in heredity of common diseases: a novel method to calculate heritability of a polymorphism |
Q28655113 | Data use under the NIH GWAS data sharing policy and future directions |
Q28742717 | Database of genetic studies of bipolar disorder |
Q58554692 | Detecting significant genotype-phenotype association rules in bipolar disorder: market research meets complex genetics |
Q38153338 | Disorders and borders: psychiatric genetics and nosology |
Q38934782 | Diversity in non-repetitive human sequences not found in the reference genome |
Q52713731 | Drosophila as a Model Organism for the Study of Neuropsychiatric Disorders |
Q33769815 | Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder |
Q38575703 | Epilepsy and bipolar disorder |
Q87701298 | Evaluation of European Schizophrenia GWAS Loci in Asian Populations via Comprehensive Meta-Analyses |
Q35908050 | Examining gene-environment interactions in comorbid depressive and disruptive behavior disorders using a Bayesian approach |
Q47563699 | Exome sequencing of a large family identifies potential candidate genes contributing risk to bipolar disorder |
Q35668704 | Explore the Features of Brain-Derived Neurotrophic Factor in Mood Disorders |
Q89581678 | Further Evidence of an Association between NCAN rs1064395 and Bipolar Disorder |
Q33780246 | Gene expression and genetic variation data implicate PCLO in bipolar disorder |
Q38054178 | Genetic and neurocognitive foundations of emotion abnormalities in bipolar disorder |
Q33949729 | Genetic architectures of psychiatric disorders: the emerging picture and its implications |
Q43991321 | Genetic heterogeneity according to age at onset in bipolar disorder: a combined positional cloning and candidate gene approach |
Q54967408 | Genetic variant for behavioral regulation factor of executive function and its possible brain mechanism in attention deficit hyperactivity disorder. |
Q34963267 | Genetic variants on 3q21 and in the Sp8 transcription factor gene (SP8) as susceptibility loci for psychotic disorders: a genetic association study. |
Q47213690 | Genetics and psychiatry: a proposal for the application of the precautionary principle |
Q33666458 | Genetics of Psychosis in Alzheimer Disease |
Q55881287 | Genetics of bipolar disorder |
Q29417107 | Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder |
Q28943290 | Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes |
Q29417149 | Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder |
Q29417042 | Genome-wide association study of Alzheimer's disease with psychotic symptoms |
Q35715185 | Genome-wide association study of behavioural and psychiatric features in human prion disease |
Q21261478 | Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1 |
Q34147518 | Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned |
Q37226546 | Genome-wide association study of suicide attempts in mood disorder patients |
Q28943523 | Genome-wide association study on bipolar disorder in the Bulgarian population |
Q37830958 | Genome-wide association: from confounded to confident. |
Q45817101 | Genome-wide searches for bipolar disorder genes |
Q36496092 | Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. |
Q28657831 | Genomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolate |
Q37780792 | Genomics and pharmacogenomics of schizophrenia |
Q40607073 | Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1. |
Q24597718 | Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis |
Q28114916 | Identification of the BRD1 interaction network and its impact on mental disorder risk |
Q48148747 | Imaging genetics: implications for research on variable antidepressant drug response |
Q36791694 | Impact of a cis-associated gene expression SNP on chromosome 20q11.22 on bipolar disorder susceptibility, hippocampal structure and cognitive performance |
Q34080310 | Integrated neurobiology of bipolar disorder |
Q98623806 | Integrative analyses prioritize GNL3 as a risk gene for bipolar disorder |
Q35100070 | Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling |
Q34113404 | Investigation of manic and euthymic episodes identifies state- and trait-specific gene expression and STAB1 as a new candidate gene for bipolar disorder |
Q38687831 | Longitudinal differences in white matter integrity in youth at high familial risk for bipolar disorder |
Q35246365 | MGAS: a powerful tool for multivariate gene-based genome-wide association analysis |
Q35549324 | Measures of current alcohol consumption and problems: two independent twin studies suggest a complex genetic architecture |
Q24612743 | Meta-analysis of genome-wide association studies identifies common variants in CTNNA2 associated with excitement-seeking. |
Q43547922 | Modifiers and subtype-specific analyses in whole-genome association studies: a likelihood framework |
Q34516774 | Molecular sex differences in human serum |
Q45386905 | Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries |
Q64978263 | Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA. |
Q44362189 | Nominal association between a polymorphism in DGKH and bipolar disorder detected in a meta-analysis of East Asian case-control samples. |
Q89747364 | Novel genetic susceptibility loci identified by family based whole exome sequencing in Han Chinese schizophrenia patients |
Q34138509 | Overview of the Genetics of Major Depressive Disorder |
Q34146222 | Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder |
Q33655590 | Physical Activity Modulates Common Neuroplasticity Substrates in Major Depressive and Bipolar Disorder |
Q34764142 | Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach |
Q24612437 | Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor |
Q35986258 | Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors |
Q35203647 | Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism |
Q42726526 | Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network. |
Q35136958 | Random-Effects Model Aimed at Discovering Associations in Meta-Analysis of Genome-wide Association Studies |
Q37927126 | Recent genomic advances in schizophrenia |
Q48229634 | Refinement of chromosome 3p22.3 region and identification of a susceptibility gene for bipolar affective disorder |
Q59790783 | Replicated associations of FADS1, MAD1L1, and a rare variant at 10q26.13 with bipolar disorder in Chinese population |
Q48932388 | Replication of association of 3p21.1 with susceptibility to bipolar disorder but not major depression |
Q57405074 | Reply to “Replication of association of 3p21.1 with susceptibility to bipolar disorder but not major depression” |
Q33877575 | Selected rapporteur summaries from the XX World Congress of Psychiatric Genetics, Hamburg, Germany, October 14-18, 2012. |
Q37784094 | Synthetic associations in the context of genome-wide association scan signals |
Q33643846 | The DAOA/G30 locus and affective disorders: haplotype based association study in a polydiagnostic approach |
Q38078013 | The Implications of Genomics on the Nursing Care of Adults With Neuropsychiatric Conditions |
Q41301586 | The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability |
Q47380947 | The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders. |
Q85032076 | The future of depression research |
Q37914871 | The genetic blueprint of major depressive disorder: contributions of imaging genetics studies |
Q92453423 | The genetics of bipolar disorder |
Q91272520 | The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine |
Q39030396 | The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders |
Q36019033 | The role of protein intrinsic disorder in major psychiatric disorders |
Search more.